From: Determination of flutamide and two major metabolites using HPLC–DAD and HPTLC methods
Parameters | HPTLC method | HPLC method | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spiked human plasma samples | Spiked urine samples | Spiked human plasma samples | Spiked urine samples | |||||||||
Flutamide | Flu-1 | Flu-3 | Flutamide | Flu-1 | Flu-3 | Flutamide | Flu-1 | Flu-3 | Flutamide | Flu-1 | Flu-3 | |
Rangea | 0.30–3.0 | 0.30–3.0 | 0.30–3.0 | 0.3–4.0 | 0.3–2.5 | 0.3–4.0 | 2–50 | 2–50 | 15–200 | 2–50 | 2–50 | 15–200 |
Slope | − 655.53b 5414.98c | − 1659.60c 12446.00d | − 455.09c 2573.60d | − 261.41c 41861.50d | − 2182.80c 13125.00d | − 139.66c 1829.70d | 60.0650 | 41.5830 | 5.8755 | 51.8810 | 37.2350 | 6.3446 |
Intercept | 665.50 | 3039.00 | 1240.80 | 1385.10 | 3066.40 | 305.60 | − 13.2490 | − 2.8848 | 25.9910 | − 21.3530 | − 0.8850 | 35.0270 |
Correlation (r) | 0.9998 | 0.9998 | 0.9992 | 0.9997 | 0.9994 | 0.9996 | 0.9999 | 0.9997 | 0.9999 | 0.9998 | 0.9999 | 0.9997 |
LLOQ | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 2.0 | 2.0 | 15.0 | 2.0 | 2.0 | 15.0 |